Application no. and date | 05756320.7 (espacenet) (Federated) (European Patent Register), 20050520 | Patent/reg. no. and date | DK/EP 1758610, 20120704 | Publication date | 20070307 | Priority no. and date | US 572973 P, 20040520, US 635380 P, 20041210, US 671281 P, 20050414, US 680447 P, 20050512 | EP pub. no. and date |
EP 1758610 20070307 | Effective date | | Applicant/owner | ZymoGenetics, Inc., 1201 Eastlake Avenue East
Seattle, WA 98102, US | Applicant ref. no. | 12086-7.DK | Inventor | FOSTER, Donald, C., 3002 NE 181st Street
Lake Forest Park, WA 98155, US, HOLLY, Richard, D., 12539 10th Avenue NW
Seattle, WA 98177, US, KINDSVOGEL, Wayne, R., 6014 24th Avenue NE
Seattle, WA 98115, US, HUGHES, Steven, D., 5530 NE 187th Street
Kenmore, WA 98028, US, CLEGG, Christopher, H., 11215 2nd Avenue NW
Seattle, WA 98177, US, JOHNSON, Rebecca, A., 5015 42nd Avenue SW
Seattle, WA 98136, US, HEIPEL, Mark, D., 8021 Earl Avenue NW
Seattle, WA 98117, US, SIVAKUMAR, Pallavur, V., 7107 32nd Avenue NW
Seattle, WA 98112, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 38/20 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | Title | Fremgangsmåder til behandling af cancer ved hjælp af IL-21 og monoklonal antistofterapi | Int. application no. | US2005019126 | Int. publication no. | WO2005113001 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|